The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
about
Optimal usage of the GnRH antagonists: a review of the literatureIVF and breast cancer: a systematic review and meta-analysisGnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphologyImpact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled TrialOvarian hyperstimulation syndrome- an optimal solution for an unresolved enigma.The Luteal Phase after GnRHa Trigger-Understanding An EnigmaGonadotropin-releasing hormone agonist triggering is effective, even at a low dose, for final oocyte maturation in ART cycles: Case series.Triggering final follicular maturation--hCG, GnRH-agonist or both, when and to whom?Higher clinical pregnancy rates from frozen-thawed blastocyst transfers compared to fresh blastocyst transfers: a retrospective matched-cohort study.Gonadotropin-releasing hormone agonist for oocyte triggering in endometrial preparation of letrozole stimulation protocols does not affect clinical outcome of frozen-thawed embryo transferThe optimal duration of progesterone supplementation in pregnant women after IVF/ICSI: a meta-analysis.GnRH agonist triggering affects the kinetics of embryo development: a comparative study.Use of gonadotropin-releasing hormone agonist trigger during in vitro fertilization is associated with similar endocrine profiles and oocyte measures in women with and without polycystic ovary syndrome.HCG (1500IU) administration on day 3 after oocytes retrieval, following GnRH-agonist trigger for final follicular maturation, results in high sufficient mid luteal progesterone levels - a proof of concept.Ultrasound for monitoring controlled ovarian stimulation: a systematic review and meta-analysis of randomized controlled trials.British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome.Characterization of Gonadotrope Secretoproteome Identifies Neurosecretory Protein VGF-derived Peptide Suppression of Follicle-stimulating Hormone Gene Expression.An update on the prevention of ovarian hyperstimulation syndrome.Comparison of two different dosage of GnRH agonist as ovulation trigger in oocyte donors: a randomized controled trialOptimal embryo transfer strategy in poor response may include freeze-all.Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.A randomized comparison of the efficacy, side effects and patient convenience between vaginal and rectal administration of Cyclogest® when used for luteal phase support in ICSI treatment
P2860
Q21245566-53C4C688-1C28-48EE-A7F6-DECC3319E479Q28295207-4F175FCE-4C74-491E-9D4C-7F686011EC56Q31060385-7F8563DE-F459-4475-914B-81F0870F503CQ33799681-87B5FA11-0CFC-4A21-A71B-1A3A9ABEF50FQ34249374-84E3091A-A481-4AF2-B6A2-B4DBA7A23EA9Q34458877-0832A744-B4BF-4D7D-8B27-19F9E54C17E2Q35173095-9EADED6D-4084-46A1-8021-D0F0FE84A53AQ35986810-91470EB6-3C18-4649-9989-7434DB7D4FE4Q36192122-5CBEEBA4-70EC-4CA6-9D3B-66E28C17752BQ36412114-280EB628-1BC2-4BBA-8F2D-4647845D4346Q36552704-94A24481-1099-4AE4-B035-5BDF6D335BEBQ36783410-D1D9D41B-F4F5-4B10-85FA-381F0C6AAAB1Q36900329-956BCA88-4DBA-4C34-88CB-D7273240AF42Q37684179-9C768E54-5D80-4CB7-8920-767626C9C160Q38123125-7D7F664F-B0B1-4C10-A39A-BA31BBCDA81DQ38266109-7714558E-F196-4576-B0B3-9495F6467A80Q38755269-313E9626-9205-4FEC-94F1-62C7B3F48EAFQ38829575-E80A473B-148A-416A-A18F-263EBC71799DQ41545744-85E756B9-4AAD-498B-ABD0-CFE8522E835BQ41597978-9D272C13-CEB9-4AA1-AF43-94803AEB71A2Q48572942-E1139DD9-8401-4C52-9F53-13602C8A82DCQ56873436-D57E68BB-DF6B-4A7F-9026-FD86EB0E3CAB
P2860
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The luteal phase after GnRH-ag ...... esent and future perspectives.
@en
The luteal phase after GnRH-ag ...... esent and future perspectives.
@nl
type
label
The luteal phase after GnRH-ag ...... esent and future perspectives.
@en
The luteal phase after GnRH-ag ...... esent and future perspectives.
@nl
prefLabel
The luteal phase after GnRH-ag ...... esent and future perspectives.
@en
The luteal phase after GnRH-ag ...... esent and future perspectives.
@nl
P2093
P1476
The luteal phase after GnRH-ag ...... resent and future perspectives
@en
P2093
B Alsbjerg
E G Papanikolaou
Human M Fatemi
N P Polyzos
P304
P356
10.1016/J.RBMO.2011.11.001
P577
2011-11-09T00:00:00Z